ISBE 2019

Porcine extracellular matrix hydrogel delivery incorporated with Nano-Ghosts for cardiac regeneration

Tzila Davidov Nitzan Letko Khait Marcelle Machluf
Biotechnology and Food Engineering, Technion – Israel Institute of Technology, Haifa, Israel

Tissue engineering has been widely studied in cardiac regeneration field for treatment of progressive heart failure post-myocardial infarction, presenting new biomaterials as a therapeutic approach that may delay disease progression and possibly regenerate the scar tissue. As a biomaterial for tissue engineering, porcine extracellular matrix (pECM) has gained growing attention, due to its intrinsic scaffolding and bioactive properties. Injectable scaffolds offer the prospective advantage of minimally invasive administration directly into the myocardium, and possible delivery of bioactive compounds and cells. We have previously developed an injectable cardiac pECM-based hydrogel shown to support mesenchymal stem cells (MSCs) and human induced pluripotent stem cells (hiPSCs) cultivation, and affect cell morphology in vitro, and to improve cardiac function in rat models in vivo.

In the present study, we hypothesized that cardiac pECM hydrogel delivering hiPSCs and pro-regenerative compounds will provide an optimal scaffold for cardiac tissue regeneration. The Nano-Ghosts (NGs) are vesicles, which derived from the cell membranes of MSCs, and as such, maintain the MSCs membrane characteristics. The NGs were incorporated into the cardiac pECM hydrogel and may serve to promote regenerative processes. Moreover, they can be used to deliver a drug of choice, as well as growth factors to the infarct area. hiPSCs differentiation on the cardiac pECM hydrogel was enhanced towards the cardiac lineage when introduced with or without the NGs. Furthermore, NGs were shown to be uptaken by hiPSCs dispersed evenly in the pECM hydrogel and proved to modulate inflammation processes.

To conclude, we propose a composite platform of cardiac pECM hydrogel combining the delivery of hiPSCs and the novel NGs delivery system, which holds the potential for improved personalized cardiac regenerative medicine.









Powered by Eventact EMS